BIIB Competitors
Biogen Inc.
$232.83
+$3.93(+1.72%)
72
Overall
80
Value
91
Tech
47
Quality
Market Cap
$33.82B
Volume
1.95M
52W Range
$138.00 - $230.49
Target Price
$239.19
BIIB competitors: AMGN, GILD, ABBV, PFE, JNJ. Biogen Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
BIIB Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $425.63 | $223.19B | $22.94 | 2.34% | 65 |
| GILD Gilead Sciences, Inc. | $153.54 | $183.41B | $-0.47 | 2.12% | 73 |
| ABBV AbbVie Inc. | $283.61 | $484.83B | $13.94 | 2.41% | 70 |
| PFE Pfizer Inc. | $29.23 | $161.70B | $2.96 | 5.89% | 70 |
| JNJ Johnson & Johnson | $252.63 | $599.12B | $11.09 | 2.09% | 56 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $232.83 | +1.7% | 1.95M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |